Search the Newsreel

Walleye Capital LLC Invests $1.53 Million in Savara Inc. $SVRA

Walleye Capital LLC has initiated a new position in Savara Inc. (NASDAQ:SVRA) by acquiring 248,720 shares valued at approximately $1.53 million during the second quarter. Despite mixed analyst sentiment, with a "Moderate Buy" consensus but recent downgrades, institutional investors collectively hold 87.93% of the …

D.A. Davidson & CO. Lowers Position in Novartis AG $NVS

D.A. Davidson & CO. reduced its stake in Novartis AG (NYSE:NVS) by 23.4% in the second quarter, selling 49,798 shares and holding 163,017 shares valued at $25.55 million. Despite this, several other institutional investors, including Auto Owners Insurance Co. and Morgan Stanley, significantly increased …

Harvard Ave Acquisition Corporation Revenue Breakdown – NASDAQ:HAVA

Savara (NASDAQ:SVRA) Stock Rating Lowered by Wall Street Zen

Wall Street Zen has downgraded Savara (NASDAQ:SVRA) from a "hold" to a "sell" rating, despite a broader analyst consensus of "Moderate Buy" with a $10.14 price target. The company recently reported a quarterly loss of $0.16 per share, missing expectations, and analysts have lowered …

Aardvark Therapeutics (NASDAQ:AARD) Raised to "Sell" at Wall Street Zen

Wall Street Zen upgraded Aardvark Therapeutics (NASDAQ:AARD) from "strong sell" to "sell," while the broader analyst consensus on MarketBeat remains a "hold" with a $16.30 price target. The clinical-stage biopharmaceutical company, specializing in treatments for autoimmune and inflammatory diseases, reported a quarterly loss of …

General Atlantic group (PHVS) discloses 5.36M Pharvaris shares, 7.6% ownership

General Atlantic entities have disclosed a beneficial ownership of 5,359,727 ordinary shares in Pharvaris N.V. (PHVS), representing a 7.6% stake in the company. This disclosure was made via a Schedule 13G/A filing, with General Atlantic PH B.V. identified as the sole record holder. The …

H.C. Wainwright reiterates Pharvaris stock rating on regulatory progress

H.C. Wainwright has reiterated a Buy rating and a $60.00 price target for Pharvaris B.V. (NASDAQ:PHVS) due to positive regulatory updates for its hereditary angioedema treatments. The FDA accepted the New Drug Application for deucrictibant IR capsule with a PDUFA action date of April …

Stockholder Alert: Robbins LLP Informs Investors of the Aardvark Therapeutics, Inc. (UWM) Class Action

Robbins LLP has filed a class action lawsuit against Aardvark Therapeutics, Inc. (NASDAQ: AARD) on behalf of investors who purchased shares during its February 13, 2025 IPO or between February 13, 2025 and May 14, 2026. The lawsuit alleges that Aardvark misled investors regarding …

Why Is Teledyne Technologies (TDY) Paying a 52% Premium for Varex (VREX)?

Varex Imaging Corporation (NASDAQ:VREX) surged 48.5% to $18.42 on August 10 after Teledyne Technologies Incorporated (NYSE:TDY) agreed to acquire the X-ray technology company for $18.90 per share in cash. The offer represents a 52% premium to Varex's unaffected closing price and values the transaction …

BIRIKIM VARLIK YONETIM (BRKVY) Hisse Senedi

HC Wainwright Brokers Lower Earnings Estimates for Savara

HC Wainwright has lowered its Q3 2026 earnings per share estimate for Savara to a loss of $0.16, down from $0.15, and projects full-year losses through 2028. This adjustment follows Savara's Q2 earnings report, where the company missed consensus estimates with a loss of …

GELECEK VARLIK YONETIMI (GLCVY) Hisse Senedi

Vardhman Special Steels Share Price Target 2027, 2028 and 2030: Long Term Analyst Forecast

Vardhman Special Steels Share Price Target 2027 to 2030: Analyst

Tvardi: Q2 Earnings Snapshot

Mirae Asset Global Investments Co. Ltd. Purchases 56,424 Shares of Novartis AG $NVS

Mirae Asset Global Investments Co. Ltd. significantly increased its stake in Novartis AG (NVS) by 40.4% in the second quarter, acquiring an additional 56,424 shares, bringing its total holdings to 195,986 shares valued at approximately $30.7 million. Other institutional investors also expanded their positions, …

VBL Share Price Today - Varun Beverages Stock Analysis

Varroc Engineer Consolidated June 2026 Net Sales at Rs 2,634.24 crore, up 29.92% Y-o-Y

Solvar (ASX:SVR) Dividend Focus: Assessing Franking Benefits, Yield and Future Income Factors

Pharvaris President Lu Peng Reports Two RSU Tax Withholding Share Dispositions

Pharvaris N.V. President Lu Peng reported two share dispositions on August 11 and 12, 2026, totaling 226 shares. These transactions were related to shares withheld by the company to cover tax obligations arising from RSU vesting. Following these dispositions, Lu Peng's direct beneficial ownership …

Pharvaris (NASDAQ:PHVS) Stock Price Expected to Rise, Royal Bank Of Canada Analyst Says

REG - Chenavari Toro IncFd - Scrip Dividend Election Price

Update: Market Chatter: Novartis Wins UK Court Challenge to Entresto Patent

(Updates with response from a Novartis spokesperson in the fourth and fifth paragraphs.)Novartis (NVS) defeated a bid by Accord Healthcare to invalidate its Entresto patent, with a UK court ruling that the patent and a related protection certificate remain valid, Reuters reported Silver Upgrade …

Novartis Wins UK Court Challenge to Entresto Patent

Novartis has successfully defended its patent for the blockbuster heart drug Entresto in a UK court challenge. The article, published by MT Newswires, indicates this as a significant win for the pharmaceutical giant. Further details require a membership to the financial news platform.

Pharvaris (NASDAQ:PHVS) Given New $75.00 Price Target at Citizens Jmp

Novartis defeats UK court bid to invalidate blockbuster drug Entresto patent

Novartis has successfully defended its patent for the heart drug Entresto in a UK court against Accord Healthcare, a subsidiary of Intas Pharmaceuticals, which intended to launch a generic version. The High Court rejected Accord's claim that Novartis's patent was invalid, affirming the patent's …

HC Wainwright Has Pessimistic View of Savara FY2029 Earnings

HC Wainwright has revised its FY2029 EPS forecast for Savara Inc. (NASDAQ:SVRA) down to $0.09 from $0.11, while projecting FY2030 EPS at $0.37. This revision is still notably above the current full-year consensus estimate of a $0.57 loss per share. Savara recently reported a …

Novartis AG $NVS Shares Purchased by Mission Wealth Management LP

Mission Wealth Management LP significantly increased its stake in Novartis AG (NYSE:NVS) during the second quarter, purchasing an additional 9,086 shares to bring its total holdings to 19,690 shares valued at approximately $3.09 million. Other institutional investors also expanded their positions, though hedge funds …

SOA Wealth Advisors LLC. Buys 14,416 Shares of Novartis AG $NVS

SOA Wealth Advisors LLC. significantly increased its stake in Novartis AG (NYSE:NVS) by 4,316.2% in the second quarter, acquiring 14,416 additional shares to reach a total of 14,750 shares valued at $2.31 million. Other institutional investors also adjusted their positions in Novartis, with institutions …

BOE Varitronix Sets August Board Meeting to Approve Interim Results and Consider Dividend

Pharvaris (NASDAQ:PHVS) Reaches New 12-Month High - What's Next?

Pharvaris (NASDAQ:PHVS) recently hit a new 52-week high of $36.65, with a current market capitalization of $2.38 billion, despite missing its latest quarterly earnings estimate. Analyst sentiment is generally positive with a "Moderate Buy" consensus and an average price target of $50.08, though some …

Citizens raises Pharvaris stock price target to $75 on trial progress

Citizens has increased its price target for Pharvaris B.V. to $75.00 from $74.00, maintaining a Market Outperform rating, due to ongoing trial progress. The company's stock has surged 70% in the past year, and key Phase 3 CHAPTER-3 data is expected this quarter. Pharvaris …

Dimensional Fund Advisors LP Has $4.36 Million Stock Holdings in Varonis Systems, Inc. $VRNS

Dimensional Fund Advisors LP significantly increased its stake in Varonis Systems, Inc. (NASDAQ:VRNS) by 556% in the first quarter, now holding 203,037 shares valued at approximately $4.36 million. This move is part of broader institutional interest, with hedge funds owning 95.65% of the company. …